Nomura (NMR) vs XP (XP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XP (XP) has outperformed Nomura (NMR) over the past year, gaining 79.4% versus a gain of 34.0%. Over five years, NMR leads with a +94.5% price change compared with -19.6% for XP. Nomura is the larger company by market cap ($27.85 billion vs $14.98 billion), about 1.9 times the size.
On valuation, XP trades at a lower forward P/E (11.9x vs 17.0x for Nomura). Nomura offers the higher dividend yield (535.15% vs 6.87%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMR | XP |
|---|---|---|
| Share price | $9.53 | $29.53 |
| Market cap | $27.85B | $14.98B |
| 1-day change | -2.56% | -0.67% |
| YTD return | +13.59% | +80.39% |
| 1-year return | +34.04% | +79.40% |
| 5-year return | +94.49% | -19.56% |
| P/E ratio (TTM) | 11.08 | 15.54 |
| Forward P/E | 17.02 | 11.95 |
| EPS (TTM) | $0.86 | $1.90 |
| Dividend yield | 535.15% | 6.87% |
| Annual dividend | $51.00 | $2.03 |
| Revenue (latest FY) | $16.74B | — |
| Revenue growth (YoY) | +15.25% | — |
| Net income (latest FY) | $346.00M | — |
| Net margin | 2.07% | — |
| 52-week high | $10.94 | $30.22 |
| 52-week low | $6.71 | $14.80 |
| Distance from 52-week high | -12.89% | -2.27% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +17.73% | -13.88% |
| Average volume | 795.55K | 6.75M |
| Shares outstanding | 2.92B | 405.69M |
| Employees | 28,677 | — |
| Sector | Finance | Finance |
| Industry | Investment Bankers/Brokers/Service | Investment Bankers/Brokers/Service |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XP has outperformed NMR by 45.4 percentage points over the past year.
- XP trades at a higher earnings multiple (15.5x vs 11.1x trailing P/E).
- Nomura offers a meaningfully higher dividend yield (535.15% vs 6.87%).
About Nomura
NMR stock →Nomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide.
Finance · Investment Bankers/Brokers/Service · 28,677 employees
About XP
XP stock →XP Inc. engages in the provision of financial products and services in Brazil.
Finance · Investment Bankers/Brokers/Service
NMR vs XP FAQ
Which is bigger, Nomura or XP?
Nomura (NMR) is larger, with a market capitalization of $27.85B compared with $14.98B for XP (XP).
Which stock has performed better over the past year, NMR or XP?
XP returned +79.40% over the past 12 months, compared with +34.04% for NMR (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NMR or XP?
NMR has the lower trailing P/E at 11.1, versus 15.5 for XP. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Nomura or XP?
Nomura has the higher yield at 535.15%, compared with 6.87% for XP.
Are Nomura and XP in the same industry?
Yes. Both are classified in the Investment Bankers/Brokers/Service industry within the Finance sector.